The Diagnostic and Prognostic Value of Serum Procalcitonin among Ventilator Associated Pneumonia Patients* - Open Journal of Respiratory Diseases

OJRD > Vol.3 No.2, May 2013

The Diagnostic and Prognostic Value of Serum Procalcitonin among Ventilator Associated Pneumonia Patients* ()

HTML

Download as PDF (Size: 196KB) PP. 73-78

DOI: 10.4236/ojrd.2013.32012 4,491 Downloads 7,749 Views Citations

Author(s)

Ashraf Abd El Halim, Adel Attia, Taysser Zytoun, Hosam Eldeen Salah

Affiliation(s)

Chest Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Critical Care Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

ABSTRACT

Ventilator-associated pneumonia (VAP) is a complication in as many as 28% of patients who receive mechanical ventilation. Studies have consistently shown that a delay in diagnosis and treatment increases the mortality risk. The aim of this work was to clarify the role of the serum procalcitonin (PCT) in the diagnosis and the prognosis of ventilator associated pneumonia. Methods: Forty two VAP patients, 20 non VAP-ICU (on mechanical ventilation) admitted patients and 20 healthy control subjects of similar age and sex were included in the study. PCT levels in serum samples were measured in all subjects. Results: There was a highly statistically significant difference (p value < 0.001) between VAP patients on one side and non VAP-ICU patients and healthy control subjects on the other side regarding the mean values of PCT. Also, the mean values of PCT were statistically significantly higher (p < 0.001) among died VAP group than the survivor VAP group. There was a statistically positive correlation (p < 0.01) between mortality prediction scores (APACHE II (R = 0.449), CRIP (R = 0.403) and SOFA (R = 0.437)) and initial PCT serum levels. Conclusions: This study found that the increased PCT serum level is an important diagnostic tool for VAP and the PCT serum levels can predict the outcome of VAP patients. We recommend other larger studies to augment our findings.

KEYWORDS

Ventilator-Associated Pneumonia (VAP); Procalcitonin (PCT); Acute Physiology and Chronic Health Evaluation II (APACHE II); The Sequential Organ Failure Assessment Score (SOFA); Clinical Pulmonary Infection Score (CPIS)

Share and Cite:

Halim, A. , Attia, A. , Zytoun, T. and Salah, H. (2013) The Diagnostic and Prognostic Value of Serum Procalcitonin among Ventilator Associated Pneumonia Patients*. Open Journal of Respiratory Diseases, 3, 73-78. doi: 10.4236/ojrd.2013.32012.

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies